Locations:

Tag: james leverenz

February 20, 2018/Basic & Translational Science

Reversal of Alzheimer’s in Mouse Model Boosts BACE1 Inhibitors’ Prospects in Humans

Most substantial reversal of amyloid deposition in an animal study to date

18-NEU-509-Nakamura-Volumetric-MRI-650×450

January 4, 2018/Neurosciences/Technology & Innovation

Making the Most of Brain Imaging Through Quantitative Volumetric Analysis

Applications in MS, neurodegenerative disease and epilepsy

October 25, 2016/Geriatrics

Aducanumab for Alzheimer’s: Putting PRIME in Perspective (Video)

A brain health expert looks ahead to phase 3 testing

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy